MOLECULARHEALTH

Serial Number 85583366
Registration 4975047
701

Registration Progress

Application Filed
Mar 29, 2012
Under Examination
Approved for Publication
Published for Opposition
Registered
Jun 7, 2016

Attorney Assistance

Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2016-06-07)
Due: Jun 07, 2026 308 days

Trademark Image

MOLECULARHEALTH

Basic Information

Serial Number
85583366
Registration Number
4975047
Filing Date
March 29, 2012
Registration Date
June 7, 2016
Drawing Code
4

Status Summary

Current Status
Active
Status Code
701
Status Date
Jun 7, 2023
Registration
Registered
Classes
042 044

Rights Holder

MOLECULAR HEALTH GMBH

16
Address
Kurfürstenanlage 21
HEIDELBERG 69115
DE

Ownership History

Molecular Health AG

Original Applicant
99
4010 Basel CH

MOLECULAR HEALTH GMBH

New Owner Before Publication #1
16
HEIDELBERG DE

MOLECULAR HEALTH GMBH

Original Registrant
16
HEIDELBERG DE

Legal Representation

Attorney
Robert S. Weisbein

USPTO Deadlines

Next Deadline
308 days remaining
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2016-06-07)
Due Date
June 07, 2026
Grace Period Ends
December 07, 2026

Application History

50 events
Date Code Type Description Documents
Jun 8, 2025 REM2 E COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED Loading...
Jun 7, 2023 NAS8 E NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED Loading...
Jun 7, 2023 8.OK O REGISTERED - SEC. 8 (6-YR) ACCEPTED Loading...
Jun 5, 2023 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Dec 17, 2022 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Dec 17, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Dec 17, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Dec 17, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Dec 17, 2022 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Dec 6, 2022 ES8R I TEAS SECTION 8 RECEIVED Loading...
Jun 7, 2021 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Jun 7, 2016 R.SR A REGISTERED-SUPPLEMENTAL REGISTER Loading...
May 5, 2016 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Apr 28, 2016 CNTA O APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER Loading...
Apr 27, 2016 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Apr 27, 2016 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Apr 27, 2016 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Apr 27, 2016 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Apr 26, 2016 ZZZX Z PREVIOUS ALLOWANCE COUNT WITHDRAWN Loading...
Mar 29, 2016 PBCR Z WITHDRAWN FROM PUB - OG REVIEW QUERY Loading...
Mar 11, 2016 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Mar 8, 2016 CNTA O APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER Loading...
Mar 4, 2016 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 3, 2016 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 3, 2016 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Dec 21, 2015 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Dec 21, 2015 GNRT O NON-FINAL ACTION E-MAILED Loading...
Dec 21, 2015 CNRT R NON-FINAL ACTION WRITTEN Loading...
Dec 9, 2015 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Dec 9, 2015 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Nov 30, 2015 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Oct 19, 2015 DOCK D ASSIGNED TO EXAMINER Loading...
May 31, 2015 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
May 31, 2015 GNRT O NON-FINAL ACTION E-MAILED Loading...
May 31, 2015 CNRT R NON-FINAL ACTION WRITTEN Loading...
May 6, 2015 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
May 6, 2015 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Apr 28, 2015 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Loading...
Oct 29, 2014 GNS2 O NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED Loading...
Oct 29, 2014 GNSI S INQUIRY TO SUSPENSION E-MAILED Loading...
Oct 29, 2014 CNSI R SUSPENSION INQUIRY WRITTEN Loading...
Oct 7, 2014 RCCK S SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Loading...
Aug 20, 2014 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Apr 7, 2014 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Apr 7, 2014 GNSL S LETTER OF SUSPENSION E-MAILED Loading...
Apr 7, 2014 CNSL R SUSPENSION LETTER WRITTEN Loading...
Mar 20, 2014 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 20, 2014 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 14, 2014 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Loading...
Oct 4, 2013 GNS2 O NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED Loading...

Detailed Classifications

Class 042
Data collection for medical and scientific research purposes, namely, the collection and systematic sorting of clinical and patient data comprising patient-specific molecular and genomic data, patient specific clinical data and scientific clinical studies; data collection for medical and scientific research purposes, namely, the collection of mathematic and statistical data, clinical data, patient data and data of clinical studies relating to clinical response to drug treatments; providing medical and scientific research information and scientific consulting in the fields of pharmaceutical side effects, genomics, biological medicine and translational medicine; providing an online database comprised of medical, pharmaceutical, biological and genomic information for scientific research purposes; providing an online searchable database in the fields of biological medical, translational medicine, interventional epidemiology, bioinformatics, clinical information technology, genomic data and genomic sequence analysis for scientific research purposes; design and development of computer software in the fields of biology, medicine, and bioinformatics; design and development of computer software for integration of patient specific data, molecular test results, clinical studies and scientific results; providing online non-downloadable computer software for use by healthcare professionals for medical treatment research; design and development of databases featuring biomarker data; providing an online searchable database for clinical and scientific research in the field of medical, diagnostic and treatment research; Software as a Service (SAAS) services featuring software for providing information for patient treatment by enabling the retrieval and correlation of genomic data, drug protocols, clinical profiling and integration and statistical analysis of data for medical purposes; providing online non-downloadable software for retrieval and correlation of genomic data, drug protocols, clinical profiling and integration and statistical analysis of data for medical diagnostic and treatment research purposes; medical research and scientific research and scientific consulting services, namely, designing and conducting drug safety and dosage assessment and drug compatibility studies in the field of cancer therapy for others; consulting services in the field of pharmaceuticals and genetics, namely, conducting drug safety and dosage assessment and in drug compatibility studies in the field of cancer treatment therapy for others relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; Providing online non-downloadable computer software for use by healthcare professionals for medical diagnostics
Class 044
Providing an online database featuring medical information and diagnostic, prophylactic and therapeutic properties of pharmaceuticals, and genomic information as it relates to medical diagnosis and treatment; pharmaceutical consulting services in pharmaceuticals and genetics in relation to patient medical treatment options; medical consulting services with respect to the treatment and diagnosis of individuals in the fields of clinical pharmacology and the analysis of dose effect relationships for treatment purposes; providing pharmaceutical information, namely, information about drug safety and drug compatibility in relation to cancer therapy and the treatment of individual patients; medical consulting services in the fields of patient treatment and treatment protocols

Additional Information

Pseudo Mark
MOLECULAR HEALTH

Classification

International Classes
042 044